Zweig-DiMenna Associates’s Patterson-UTI PTEN Stock Holding History

Zweig-DiMenna Associates’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-253,000	Closed	-$4.26M	–	121
2022 Q4	$4.26M	Buy	+253,000	New	+$4.17M	0.62%	58
2022 Q3	–	Sell	-160,000	Closed	-$2.52M	–	97
2022 Q2	$2.52M	Buy	+160,000	New	+$2.69M	0.48%	65
2015 Q3	–	Sell	-419,000	Closed	-$7.88M	–	273
2015 Q2	$7.88M	Buy	+419,000	New	+$8.69M	0.44%	68
2014 Q4	–	Sell	-339,193	Closed	-$11M	–	315
2014 Q3	$11M	Buy	+339,193	New	+$11.5M	0.48%	72
2013 Q3	–	Sell	-18,770	Closed	-$363K	–	261
2013 Q2	$363K	Buy	+18,770	New	+$410K	0.01%	171

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zweig-DiMenna Associates's PTEN Position: Q1 2023 in Review

Zweig-DiMenna Associates sold out of Patterson-UTI (PTEN) in Q1 2023, closing a stake of 253,000 shares — an estimated $4.26M sold.

Zweig-DiMenna Associates first reported a position in PTEN in Q2 2013 and held it in 5 quarters. The position peaked at $11M in Q3 2014. 285 funds tracked by Wall St. Rank hold PTEN as of Q1 2023.

Zweig-DiMenna Associates reported no remaining Patterson-UTI position as of Q1 2023 after selling out during the quarter.
Zweig-DiMenna Associates sold 253,000 Patterson-UTI shares in Q1 2023, an estimated $4.26M.
Zweig-DiMenna Associates first reported a position in Patterson-UTI in Q2 2013 and held it in 5 quarters.
Zweig-DiMenna Associates's Patterson-UTI position peaked at $11M in Q3 2014.
285 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2023.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2023, filed 28 Apr 2023.